NovaQuest Co-Investment Fund XV L.P. 13D/13G Filings for Idera Pharmaceuticals, Inc. (IDRA)

NovaQuest Co-Investment Fund XV L.P. 13D and 13G filings for Idera Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-01-18
4:54 pm
Purchase
2023-01-1713DIdera Pharmaceuticals, Inc.
IDRA
NovaQuest Co-Investment Fund XV L.P.909,326
9.700%
909,326increase
(New Position)
Filing